BioLife Sciences Inc. (OTC: BLFE) Announces Letter of Intent for Exclusive Licensing Deal With Canadian Firm
HENDERSON, NV, Feb. 02, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife Sciences (OTCPK: BLFE) is pleased to announce that it has entered into a non-binding letter of intent ("LOI") dated Febru
BioLife Sciences Inc. Seeks to Retain an Auditing and Consulting Services Firm
HENDERSON, NV, Nov. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioLife Sciences Inc. ("BioLife" or the "Company") (OTCPK: BLFE) announced that it is seeking to retain an auditing and consulting
BioLife Sciences Inc. (OTC: BLFE) Enters Into Negotiations for Exclusive Licensing Deal With Canadian Firm
HENDERSON, NV, Sept. 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioLife Sciences (OTCPK: BLFE) is pleased to announce that it has entered into negotiations with Canadian Firm--Work In Motion to
BioLife Sciences Inc. Expands Product Offerings in the Orthomolecular Medicine and Natural Health Markets With a Focus on Hemp Products
HENDERSON, Nev., Aug. 24, 2022 (GLOBE NEWSWIRE) -- BioLife Sciences Inc. ("BioLife" or the "Company") (OTC: BLFE) announced today that it will be expanding the scope of its orthomolecular medicine a
BioLife Sciences Announces Launch of Hemp-Based Product Line
HENDERSON, Nev., Aug. 17, 2022 (GLOBE NEWSWIRE) -- BioLife Sciences Inc. ("BioLife" or the "Company") (OTC: BLFE) announced today the launch of its first line of cannabinoid consumer products. The C
BioLife Sciences Retains Benzinga for Marketing Campaign
HENDERSON, Nev., Aug. 09, 2022 (GLOBE NEWSWIRE) -- BioLife Sciences Inc. (OTCPK: BLFE) (the "Company" or BioLife), announced today that it has retained Benzinga to launch marketing and advertising s
BioLife Sciences Retains GS Whitney & Co for Corporate Relations
HENDERSON, NV, Aug. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife Sciences Inc. (OTCPK: BLFE) (the "Company" or BioLife) announced today it has engaged GS Whitney & Co. (GS Whitney) to assist in building brand awareness, providing communic
BioLife Sciences Inc. COO Details Innovation and Market Strategies in Audio Interview with SmallCapVoice.com
AUSTIN, Texas, Aug. 02, 2022 (GLOBE NEWSWIRE) -- SmallCapVoice.com Inc. ("SCV") announces the availability of a new interview with Nika Jaksic, COO of BioLife Sciences Inc. (OTCPK: BLFE) (the "Company"), to provide an overview of the Company's operatio
BioLife Sciences Retains SmallCapVoice.com for Corporate Relations Advisory Services
HENDERSON, NV, July 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife Sciences Inc. (OTCPK: BLFE) (the "Company" or BioLife), announced today that it has retained SmallCapVoice.com Inc. ("SCV
BioLife Sciences Inc. Announces SEC Qualification of Regulation A+ Tier 1 Offering
HENDERSON, NV, July 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioLife Sciences Inc. (OTC: BLFE) today announced it has successfully received qualification of its offering statement on Form 1-A
BioLife Sciences Inc. Files Form 1-A with the Securities and Exchange Commission (SEC) to Raise Capital Under a Tier I Regulation A+ Offering
HENDERSON, NV, June 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioLife Sciences Inc. (OTC: BLFE) (the "Company" or "BioLife"), announced today that it has filed Form 1-A with the Securities and
BioLife Sciences Inc. To Incorporate New Sub-Sector Dedicated To CBD
BioLife Sciences (OTCPK: BLFE), a firm dedicated to developing, licensing, and distributing antimicrobial products and disruptive technologies, announced on Tuesday that it is expanding its recently a
BioLife Sciences Inc. (OTC: Markets: BLFE) Announced Today It Will Be Expanding Its Newly Formed Orthomolecular Medicine and Natural Health Products Department With a Subsector Dedicated to Cannabidiol (CBD) Sales and Products
HENDERSON, NV, March 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioLife Sciences (OTCPK: BLFE) (the "Company" or "BioLife) is pleased to announce that it is expanding its recently announced ort
BioLife Sciences Inc. (OTC Markets: BLFE) Announced Today That the Company is Launching a New Life Sciences Division
Henderson, NV, Feb. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife Sciences (OTCPK: BLFE) is pleased to announce the launching of a new life sciences division, aimed at honing in on disrup
BioLife Sciences Inc. (OTC Markets: BLFE) Announced Today That the Company Has Finalized a Definitive Agreement With Health Box LLC for the 100% Acquisition of the Orthomolecular Medicine and Natural Health Products Company
Henderson, Nevada, Feb. 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife Sciences (OTCPK: BLFE) is pleased to announce that it has finalized a definitive agreement (the "Agreement") with Hea
BioLife Sciences Inc. (OTC Markets: BLFE) Signs LOI with Health Box LLC Towards the 100% Acquisition of the Arizona, USA Based Entity Specializing in Advanced Orthomolecular Medicine and Natural Health Products Development and Research
Toronto, Ontario, Canada, Jan. 25, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife Sciences (OTCPK : BLFE) is pleased to announce that it has entered into exclusive negotiations with Health Box
No Data